Peripheral Arterial Disease Trial, Recruiting NCT06223217 Sponsor: RenJi Hospital Condition: Peripheral Arterial Disease
Back to Peripheral Arterial Disease

Peripheral Arterial Disease Trial, Recruiting

NCT06223217
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a man or woman between 18 and 90 years old
  • You have been diagnosed with peripheral arterial disease (poor blood flow) in your legs or feet
  • You are willing and able to attend follow-up appointments at the required times
  • You understand what the study involves and are willing to sign a consent form before joining
  • During the procedure, a thin wire has already been successfully passed through the blocked or narrowed area being treated
  • There are no restrictions based on how severe your arterial disease is (confirm with trial site)

Who may not be able to join:

  • You are pregnant, or you are a woman who could potentially become pregnant
  • You are currently taking part in another clinical trial for a drug or medical device that has not yet finished
  • You are unwilling or refusing to sign the required consent form
  • You have another serious illness — such as cancer, severe liver disease, or heart failure — that significantly affects your quality of life, or you are not expected to live more than 2 years

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86-17520505530

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
1 October 2023
Est. completion
31 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

the Modified version of VascuQol Scale; the Chinese version of VascuQol Scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov